Leadership & Vision

Understanding the patient burden of living with Crohn's perianal fistulas

Clinical trial diversity is our responsibility

Maintaining trust in science is crucial to public health. Here’s how the biopharma industry can help

A data and digital transformation: driving value and innovation

Takeda breaks ground on new treatment manufacturing facility in Thousand Oaks, California, USA

New report: The impact of plasma-derived therapies in Europe

Takeda Breaks Ground on Commercial Cell Therapy Manufacturing Facility in Lexington, Massachusetts

Guided by Our Values: Supporting Global COVID-19 Response

A ‘Swiss Cheese’ Approach Can Give Us a Second Chance to Contain COVID-19

COVID-19: Working Together to Go Faster for Patients

Coronavirus: Adjusting Our Business Approach While Serving Our Patients

Rajeev Venkayya, President, Global Vaccine Business Unit on the Latest on the Coronavirus and Takeda

Shaping the Future of Healthcare: Sustainability and Davos 2020

Takeda CEO Sees a Bright Future in Globalized Pharmaceuticals Market

Grand Opening of New Dengue Vaccine Manufacturing Plant in Singen, Germany

Grand Opening of Takeda’s New Production Facility, Grange Castle, Ireland

Takeda Breaks Ground on a State-of-the-Art Facility in Osaka, Japan

Strengthening Takeda’s Global Reach by Sustaining Core Values

CEO Christophe Weber on Why Takeda’s Unique Corporate Governance Structure Works

Ramona Sequeira, President of Takeda's U.S. Business Unit, on the Many Opportunities That Lie Ahead for the “New” Takeda

Celebrating Our New Global Reach

Takeda’s Transformation: The Next Chapter

Perspectives on Confronting and Embracing Disruptions in Healthcare

Strengthening Our Global Production Network in Oranienburg

Takeda Recognized for Commitment to Quality